Prevention of Venous Thromboembolism in Patients With Cancer

Given the inconsistent prophylaxis of medical patients at risk for venous thromboembolism (VTE), VTE has become a priority for a number of integrated health systems, including the Department of Veterans Affairs. There is robust evidence supporting the importance of prophylaxis and adequate treatment of hospitalized patients, and physicians have a number of therapeutic options that can protect the patient both within the acute care setting and in the community. Oncology patients are a subpopulation that are particularly at risk for VTE due to certain tumor types and the biologic therapy, and are also at increased risk for major bleeding. This case-based program will review the known VTE risk factors, examine the risks and benefits of anticoagulation in the oncology patient, and summarize options for the clinician to appropriately manage this at-risk population.

This Simulated Live Broadcast is a 1-hour presentation, led by 2 faculty speakers and 1 moderator, that incorporates didactic lectures with case-based presentations. At the conclusion of the first week of the broadcast, the initial broadcast participants will have the opportunity to submit a moderated question to the faculty via teleconference line.

Available until September 15, 2012.
Physicians: 1.0 AMA PRA Category 1 Credit^™
Nurses: 1.0 contact hour

This activity is sponsored by Quintiles Medical Education, Inc. This activity is co-provided by Global Education Group and Quintiles Medical Education, Inc.